| Application no. and date | 07820423.7 (espacenet) (Federated) (European Patent Register), 20070920 | | Patent/reg. no. and date | DK/EP 2074141, 20160810 | | Publication date | 20090701 | | Priority no. and date | EP 06121113, 20060922 | | EP pub. no. and date |
EP 2074141 20090701 | | Effective date | | | Applicant/owner | Novo Nordisk A/S, Novo Allé, 2880 Bagsværd, DK | | Applicant ref. no. | P22282DKEP | | Inventor | RIBEL-MADSEN, Ulla, Birkely 1, 2830 Virum, DK,
LUDVIGSEN, Svend, Baunedalen 13, 3540 Lynge, DK,
HUBALEK, Frantisek, Classensgade 19 A, 2. tv., 2100 København Ø, DK,
NIELSEN, Peter Kresten, Granholmen 16, 2840 Holte, DK,
LAUTRUP-LARSEN, Inger, Kongsvænget 34, 2830 Virum, DK,
BALSCHMIDT, Per, Mortenstrupvej 42, 2970 Hørsholm, DK,
HAVELUND, Svend, Kurvej 24, 2880 Bagsværd, DK,
NARGAARD, Per, Gammel Mejerivej 7, 3050 Humlebæk, DK | | Representative | Patrade A/S, Ceresbyen 75, 8000 Århus C | | Opponent | | | IPC Class | A61K 38/28 (2006.01) , C07K 14/62 (2006.01) , C12N 15/17 (2006.01) | | Title | Proteaseresistente insulinanaloger. | | Int. application no. | EP2007059990 | | Int. publication no. | WO2008034881 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
